CURRENT ORGANIC SYNTHESIS, published by Bentham Science Publishers Ltd, is a leading journal in the field of organic chemistry and biochemistry that serves as a vital platform for researchers and professionals advancing the synthesis of organic compounds. With an ISSN of 1570-1794 and an E-ISSN of 1875-6271, it boasts a significant impact within its category, ranked in the Q3 quartile for both biochemistry and organic chemistry as of 2023. The journal covers innovative research and reviews that enhance our understanding of organic synthesis methodologies, showcasing contributions that advance the field. Operating from Sharjah, United Arab Emirates, CURRENT ORGANIC SYNTHESIS has evolved since its inception in 2005, providing access to a wealth of information essential for students, professionals, and researchers alike. While it currently does not offer open access, the journal continues to maintain a strong community of scholars dedicated to fostering dialogue and innovation in the organic sciences.

RUSSIAN CHEMICAL REVIEWS, published by the esteemed ND Zelinsky Institute of Organic Chemistry, RAS, stands as a prominent platform for disseminating high-quality research in the diverse field of chemistry. With an ISSN of 0036-021X and an E-ISSN of 1468-4837, this journal has earned its place in the Q1 quartile of Chemistry (miscellaneous) for 2023, reflecting its outstanding impact and rigorous peer-review process. The journal encompasses a wide array of topics within chemistry, providing critical reviews that advance understanding and foster collaboration among researchers, professionals, and students globally. With its consistent publication since 1970, RUSSIAN CHEMICAL REVIEWS not only serves as a valuable resource for the latest advancements in the field but also plays a crucial role in shaping future research directions. The journal is based in the Russian Federation, with its office located at 47 Leninsky Pr, Moscow 119991, RUSSIA. As an essential reference for those in the chemical sciences, it provides an ideal avenue for authors looking to publish impactful reviews that contribute to the broader scientific community.

European Journal of Medicinal Chemistry, a premier publication by Elsevier France-Editions Scientifiques Médicales Elsevier, has been at the forefront of advancing medicinal chemistry since its inception in 1974. With an impressive impact factor and ranking in the Q1 quartile across multiple categories including Drug Discovery, Medicine (miscellaneous), Organic Chemistry, and Pharmacology, this journal delivers cutting-edge research and reviews that are vital for researchers and professionals in the field. The journal’s scope encompasses the design, synthesis, and evaluation of biological activity of bioactive compounds, making it a critical resource for those looking to innovate in drug development and therapeutic strategies. Although currently not open access, subscribers can benefit from its diverse range of high-quality articles, ensuring the dissemination of knowledge in the ever-evolving landscape of medicinal chemistry. The European Journal of Medicinal Chemistry continues to play a pivotal role in shaping the future of pharmacological research and its application, thus appealing to an audience dedicated to making impactful scientific contributions.

RSC Medicinal Chemistry is a pivotal journal in the realm of medicinal chemistry, published by the esteemed Royal Society of Chemistry. With a focus on innovative research that intersects various disciplines such as biochemistry, drug discovery, pharmaceutical science, and organic chemistry, this journal serves as a vital resource for researchers, professionals, and students alike. Its impressive impact factor and notable rankings—positioning it within the Q1 and Q2 quartiles across critical categories—underscore its significance in advancing knowledge and fostering collaboration within the scientific community. RSC Medicinal Chemistry is dedicated to open access, ensuring that cutting-edge findings on drug design and therapeutic applications are freely available to enhance global research efforts. With a commitment to publication excellence from 2020 to 2024, it is a prominent platform where groundbreaking ideas meet practical implications, making it indispensable for anyone committed to the forefront of medicinal advances.

Future Medicinal Chemistry is a premier journal dedicated to the rapidly evolving fields of drug discovery, pharmacology, and molecular medicine. Published by Newlands Press Ltd in the United Kingdom, this journal has garnered significant attention within the academic community, evidenced by its 2023 category rankings in Scopus, placing it in the Q2 quartile for Drug Discovery and the Q3 quartiles for both Molecular Medicine and Pharmacology. With an ISSN of 1756-8919 and an E-ISSN of 1756-8927, Future Medicinal Chemistry has been a cornerstone of scholarly discourse since its inception in 2009, continuously contributing to the advancement of knowledge and discussion in medicinal chemistry. The journal is committed to publishing high-quality, peer-reviewed research that addresses the challenges and innovations in drug development and therapeutic strategies, making it an essential resource for researchers, professionals, and students seeking to stay at the forefront of these critical fields. Engage with the latest findings and methodologies that shape the future of medicine by exploring the wealth of information offered within Future Medicinal Chemistry.

Medicinal Chemistry is a prestigious journal published by Bentham Science Publishers Ltd, dedicated to advancing the field of drug discovery and development. Established in 2005 with a converged publication timeframe extending to 2024, this journal serves as a vital resource for researchers and professionals interested in the intricate processes of medicinal chemistry, pharmacology, and toxicology. With an ISSN of 1573-4064 and an E-ISSN of 1875-6638, it has established a notable presence in the academic community, currently positioned in Q3 of Drug Discovery category according to the 2023 quartiles. The journal's ranking in Scopus places it at 90 out of 157 in its field, showcasing its impact and relevance, with a percentile standing of 42. Although the journal is not open access, it continues to provide insightful articles and research findings that contribute significantly to the understanding and innovation in medicinal chemistry. Based in the United Arab Emirates, Medicinal Chemistry is committed to disseminating high-quality research that shapes the future of drug formulation and therapeutic advancement.

SynOpen is an esteemed open-access journal published by GEORG THIEME VERLAG KG, based in Germany, dedicated to advancing the fields of Biomaterials, Catalysis, Materials Science, and Organic Chemistry. Since its inception in 2017, the journal has established itself as a vital platform for researchers wishing to disseminate their findings in a rapidly evolving scientific landscape, earning a commendable Q2 ranking in Materials Science (miscellaneous) and Q3 in other key categories for 2023. With an increasing impact on its disciplines, SynOpen aims to foster interdisciplinary collaboration and innovation by providing unrestricted access to high-quality research, thus promoting a broader reach and visibility for authors. Scholars, professionals, and students alike can benefit from the comprehensive range of topics covered, as the journal's commitment to presenting cutting-edge studies and methodologies positions it as a crucial resource for contemporary scientific inquiry.

JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, published by the SOCIETY OF SYNTHETIC ORGANIC CHEMISTRY, JAPAN, is an esteemed publication specializing in the dynamic field of organic chemistry. With a rich history dating back to 1944, this journal aims to disseminate pivotal research findings and innovative methodologies in synthetic organic chemistry, fostering collaboration and knowledge exchange among researchers and professionals. Although it currently holds a modest ranking in the Q4 quartile for organic chemistry, its commitment to advancing the discipline remains steadfast. The journal primarily caters to scholars and students seeking to delve deeper into organic synthesis, highlighting original articles, reviews, and methodological studies. While access to the journal is not open, its contributions to the field are essential for anyone invested in understanding the complexities of organic chemistry. We invite you to explore the journal's offerings and enhance your expertise in synthetic organic processes.

Russian Journal of Bioorganic Chemistry (ISSN: 1068-1620, E-ISSN: 1608-330X), published by MAIK Nauka/Interperiodica/Springer, serves as a vital resource for researchers and professionals in the fields of bioorganic chemistry, biochemistry, and organic chemistry. With a focus on the integration of organic chemistry principles with biological processes, this journal aims to disseminate significant findings and advancements from both theoretical and practical perspectives. Although currently not open access, the journal retains a dedication to high-quality, peer-reviewed content, contributing to its reputation within the academic community. The 2023 Scopus rankings position it within the Q4 category for both biochemistry and organic chemistry, indicating its critical niche within these disciplines amid a competitive landscape. Since its inception in 1996, the journal has continued to evolve, providing enriching insights and fostering collaborations among scholars and practitioners alike, with publication converging up to the year 2024. By exploring complex biomolecular interactions and the synthesis of biologically relevant compounds, the Russian Journal of Bioorganic Chemistry remains a significant platform for advancing knowledge and innovation in the life sciences.

HETEROCYCLES, published by the Japan Institute of Heterocyclic Chemistry, stands as a pivotal journal within the fields of Analytical Chemistry, Organic Chemistry, and Pharmacology. With its ISSN 0385-5414 and E-ISSN 1881-0942, HETEROCYCLES has been a respected platform for scholarly work since its establishment in 1983, featuring innovative research up until 2022. While currently not open access, the journal is renowned for its rigorous peer-review process, ensuring the dissemination of high-quality research. Despite its Q4 ranking in the 2023 quartiles for its categories, it plays a crucial role in bridging gaps in knowledge and advancing the discourse on heterocyclic compounds, which are vital in drug discovery and development. Researchers, professionals, and students who are engaged in chemistry and pharmacology will find HETEROCYCLES an essential source of cutting-edge studies, insights, and an opportunity to contribute to the evolving landscape of these scientific fields.